Covidien CEO to retire, successor named

The board of directors of Covidien announced that Richard J. Meelia will retire as president and CEO, effective July 1. Jose E. Almeida, president of Covidien’s Medical Devices business segment, has been elected to succeed Meelia as president and CEO.

Meelia will serve as non-executive chairman of the board for a transition period of up to one year following his retirement as CEO, stated the company.

Almeida was appointed to his current position as head of medical devices in October 2006. The medical devices business accounts for about two-thirds of Covidien’s total annual revenue and three-quarters of its operating profit.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup